PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling
Zhiyong Yao1, Bin Sun1, Quan Hong1
1Department of Urology, Air Force General Hospital of People's Liberation Army, Beijing, People's Republic of China.
Background:
PACE4 is a proprotein convertase capable of processing numerous substrates involved in tumor growth, invasion, and metastasis. However, the precise role of PACE4 during prostate cancer cell apoptosis has not been reported.
Methods:
In the present study, human prostate cancer cell lines DU145, LNCaP, and PC3 were transfected with PACE4 small interfering (si)RNA to investigate the underlying mechanisms of apoptosis.
Results:
We revealed that PACE4 siRNA exhibited antitumor activity by inducing apoptosis, as determined by Cell Counting Kit-8 (CCK-8), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-razolium bromide (MTT) assay, cell cycle analysis, Hoechst staining, caspase-3/7 activity, and western blot analysis. In addition, PACE4 siRNA significantly increased the ratio of Bax/Bcl-2, which led to the release of cytochrome c. Moreover, PACE4 siRNA also induced endoplasmic reticulum stress by increasing the expression of GRP78, GRP94, p-PERK, and p-eIF2α. The ratio of Bax/Bcl-2 and GRP78 were also increased in PACE4 gene knockdown prostate cancer cells compared with the control cells.
Conclusion:
These data demonstrate that PACE4 siRNA may exert its antitumor activity through mitochondrial and endoplasmic reticulum stress signaling pathways, indicating it may be a novel therapeutic target for prostate cancer.
Insights
PACE4 small interfering (si)RNA demonstrated antitumor effects in prostate cancer by inducing apoptosis. This suggests PACE4 may be a therapeutic target, acting via mitochondrial and endoplasmic reticulum stress pathways.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Proprotein convertase PACE4 processes substrates crucial for tumor progression.
- The role of PACE4 in prostate cancer cell apoptosis remains unelucidated.
Purpose of the Study:
- To investigate the role of PACE4 in prostate cancer cell apoptosis.
- To explore the therapeutic potential of targeting PACE4 in prostate cancer.
Main Methods:
- Human prostate cancer cell lines (DU145, LNCaP, PC3) were transfected with PACE4 small interfering (si)RNA.
- Apoptosis was assessed using Cell Counting Kit-8 (CCK-8), MTT assay, cell cycle analysis, Hoechst staining, caspase-3/7 activity, and western blot analysis.
Main Results:
- PACE4 siRNA induced apoptosis and exhibited antitumor activity in prostate cancer cells.
- PACE4 knockdown increased the Bax/Bcl-2 ratio, leading to cytochrome c release and activating mitochondrial apoptosis.
- Endoplasmic reticulum stress was induced, evidenced by increased GRP78, GRP94, p-PERK, and p-eIF2α expression.
Conclusions:
- PACE4 siRNA exerts antitumor effects through mitochondrial and endoplasmic reticulum stress pathways.
- Targeting PACE4 represents a potential novel therapeutic strategy for prostate cancer.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
Apoptosis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway


